IL6 and COVID-19: Though canonical markers of inflammation (IL-6, TNF-α, and CRP) have previously been shown to be associated with higher mortality in supercentenarians (53) and COVID-19 patients (54), there is an intricate interplay between immune cells and cytokine secretion (1, 6, 7, 20).